Longitudinal analysis at pre- and post-flare of T peripheral helper and T follicular helper subsets in patients with systemic lupus erythematosus.
Flare
Systemic lupus erythematosus
Tph cells
circulating Tfh cells
Journal
Immunology letters
ISSN: 1879-0542
Titre abrégé: Immunol Lett
Pays: Netherlands
ID NLM: 7910006
Informations de publication
Date de publication:
03 Aug 2024
03 Aug 2024
Historique:
received:
24
04
2024
revised:
27
06
2024
accepted:
02
08
2024
medline:
6
8
2024
pubmed:
6
8
2024
entrez:
5
8
2024
Statut:
aheadofprint
Résumé
We focused to analyze the time-course changes at pre- and post-flare of T peripheral helper (Tph) cells and circulating T follicular helper (Tfh) cells in the blood of patients with systemic lupus erythematosus (SLE) with lupus low disease activity state (LLDAS) before flare. This study included inactive (n=29) and active (n=55) patients with SLE. Tph subsets, Tfh subsets, CD11c Active SLE patients exhibited the increased frequency of Tph1, Tph2, Tfh1, and Tfh2 subsets when compared to inactive patients, but no clear changes in the other subsets. During the treatment with medications, Tph1, Tph2, and Tfh2 subsets were significantly reduced along with disease activity and Tph1 and Tph2 subsets were positively correlated with SLE disease activity index (SLEDAI). The time course analysis of patients at pre- and post-flare revealed that in the patients at LLDAS before flare, Tph subsets and Tfh subsets were relatively low levels. At the flare, Tph cells, particularly Tph1 and Tph2 subsets, were increased and correlated with SLEDAI. Furthermore, the blood levels of IFN-α2a, IFN-γ, and IFN-λ1 were low in the patients with LLDAS before flare but these IFNs, particularly IFN-λ1, were increased along with flare. Increased frequency of Tph1 and Tph2 subsets and elevated levels of serum IFN-λ1 are presumably critical for triggering of flare in SLE.
Identifiants
pubmed: 39103125
pii: S0165-2478(24)00079-8
doi: 10.1016/j.imlet.2024.106905
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106905Informations de copyright
Copyright © 2024. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Mitsuhiro Akiyama: Asahikasei Pharma Corp., Astellas Pharma Inc., Boehringer Ingelheim Co., Ltd., Eli Lilly Japan KK., Pfizer Japan Inc., and UCB Japan Co., Ltd. Tsutomu Takeuchi: AbbVie GK, Bristol-Myers KK, Chugai Pharmaceutical Co., Ltd. Noriyasu Seki, Hideto Tsujimoto, Shuhei Tanemura, Kunio Sugahara, a nd Kenji Chiba : Mitsubishi Tanabe Pharma Corporation employee